hVIVO is a full-service early-phase Contract Research Organisation (CRO) and a global leader in human challenge trials. The company provides end-to-end clinical development services, specializing in conducting human challenge trials across various infectious and respiratory indications, and offers comprehensive virology and immunology laboratory services under the hLAB brand. It was founded in 1988 and is headquartered in London, United Kingdom.